http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113041365-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-221 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-223 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-22 |
filingDate | 2021-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-113041365-B |
titleOfInvention | Targeted ultrasonic contrast agent for enhancing carotid arteriosclerosis ultrasonic diagnosis and preparation method thereof |
abstract | The invention relates to a targeted ultrasound contrast agent for enhancing ultrasonic diagnosis of carotid arteriosclerosis and a preparation method thereof, the targeted ultrasound contrast agent for enhancing ultrasonic diagnosis of carotid arteriosclerosis is prepared from phospholipid containing hyaluronic acid and optionally mannose and derivatives thereof and bio-inert gas, the carotid arteriosclerosis targeting of the ultrasound contrast agent is realized at low cost, and the ultrasonic imaging effect of carotid arteriosclerosis is enhanced. |
priorityDate | 2021-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.